| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/15/2004 | US20040138421 ACPL DNA and polypeptides |
| 07/15/2004 | US20040138420 Fluorescent proteins |
| 07/15/2004 | US20040138417 Chimeric heteromultimer adhesins |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138168 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 07/15/2004 | US20040138167 Administering a nucleic acid; prevention infections, Dna damage, tumors,skin disorders |
| 07/15/2004 | US20040138166 Viricides; prevent reproduction, infections |
| 07/15/2004 | US20040138164 Oligonucleotides; nucleic acid; therapy, diagnosis; cardiovascular disorders, atherosclerosis, anticholesterol agents |
| 07/15/2004 | US20040138159 Oligonucletides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof |
| 07/15/2004 | US20040138158 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 07/15/2004 | US20040138156 Therapeutic regulation of deoxyribonuclease-1-like-3 activity |
| 07/15/2004 | US20040138155 for treatment of central and/or peripheral nervous system injury; neurons; fibroblast growth factor receptors; biocompatability |
| 07/15/2004 | US20040138154 Solid surface for biomolecule delivery and high-throughput assay |
| 07/15/2004 | US20040138150 Motilide compounds |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138132 Membrane translocating peptide drug delivery system |
| 07/15/2004 | US20040138130 Active modified hedgehog proteins |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138117 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040138105 Modulators of polysaccharides and uses thereof |
| 07/15/2004 | US20040138101 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 07/15/2004 | US20040137642 Major histocompatibility complex fusion protein for use as diagnostic tool in monitoring antigen specific cellular immune response |
| 07/15/2004 | US20040137632 Method for more efficient electroporation |
| 07/15/2004 | US20040137631 Processes and vectors for plastid transformation |
| 07/15/2004 | US20040137630 Using single stranded nucleotide sequences and directed recombination to generate transgenic plants; herbicide and disease resistance in plants; tissue engineering |
| 07/15/2004 | US20040137629 Using needle like projections laced with heterologous gene sequences and agitaion to transform plant cells; tissue engineering |
| 07/15/2004 | US20040137628 Selection for more efficient transformation host cells |
| 07/15/2004 | US20040137627 Using sendai viral vector as tool for transfer and expression of heterologous nucleotide sequences |
| 07/15/2004 | US20040137626 AAV ITR-mediated modulation |
| 07/15/2004 | US20040137625 Compositions and methods for drug delivery using amphiphile binding molecules |
| 07/15/2004 | US20040137624 Using recombinase directed homologous recombination to integrate exogenous DNA into the genomes of plants; tissue engineering |
| 07/15/2004 | US20040137622 Modular transfection systems |
| 07/15/2004 | US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same |
| 07/15/2004 | US20040137611 Cypridina luciferase fusion for use as diagnostic tool in monitoring synaptic response |
| 07/15/2004 | US20040137603 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137599 Leporipox-based vector vaccines |
| 07/15/2004 | US20040137598 Peptidylarginine deiminase 6 |
| 07/15/2004 | US20040137595 Mfq-111, a novel human gtpase like protein |
| 07/15/2004 | US20040137592 Comprises phosphatidyl inositol kinase related protein for use in the identification of modulators for treatment of cystic fibrosis and/or muscular disorders |
| 07/15/2004 | US20040137591 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 07/15/2004 | US20040137590 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 07/15/2004 | US20040137589 Human myosin-like polypeptide expressed predominantly in heart and muscle |
| 07/15/2004 | US20040137586 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
| 07/15/2004 | US20040137584 Biotin biosynthetic genes |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137579 Protein complexes having factor VIII:C activity and production thereof |
| 07/15/2004 | US20040137577 B7-H2 molecules, novel members of the B7 family and uses thereof |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137572 Compositions and methods for generating conditional knockouts |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137560 comprises rupturing a yeast cell in a frozen state and and mashing in a mortar with a pestle followed by dialysis; kits |
| 07/15/2004 | US20040137558 by using a culture of a microbe having an ability to produce a dipeptide from an amino acid ester and an amino acid |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137556 Yeast strains autonomously producing steroids |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137522 Genes and proteins altering Tau-related neurodegeneration |
| 07/15/2004 | US20040137513 Agonist anti-trk-c monoclonal antibodies |
| 07/15/2004 | US20040137512 Malaria plasmodium antigen polypeptide se36, method of purifyng the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137508 for drug screening agents that can modulate phosphodiesterase (PDE) activity; for diagnosis/therapy; antisense agents; genetic engineering |
| 07/15/2004 | US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137502 for diagnosis, drug screening, clinical trial monitoring, the treatment of physiological disorders or infectious disease |
| 07/15/2004 | US20040137501 Antisense modulation of TRADD expression |
| 07/15/2004 | US20040137497 using a first primer that hybridizes to the target polynucleotide, hybridizing the equal length extension products to a second primer, producing extension products from the second primer, and detecting the extension products; solid phase synthesis |
| 07/15/2004 | US20040137496 Genes encoding sulfate assimilation proteins |
| 07/15/2004 | US20040137495 Meg-4 protein |
| 07/15/2004 | US20040137493 Methods and compositions for amplifying detectable signals in specific binding assays |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137490 to decipher gene functions and to identify drug targets/drug screening; for gene expression inhibition |
| 07/15/2004 | US20040137488 Methods for identifying the activity of gene products |
| 07/15/2004 | US20040137487 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target |
| 07/15/2004 | US20040137486 correlates known sensory, physical, ingredient, or processing properties (color, taste, texture, pH, moisture content) with a spectrum of target species of microorganisms that are present |
| 07/15/2004 | US20040137485 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/15/2004 | US20040137484 Nucleic acid amplification methods |
| 07/15/2004 | US20040137483 Lipoxygenase proteins and nucleic acids |
| 07/15/2004 | US20040137482 Anti-microbial targeting chimeric pharmaceutical |
| 07/15/2004 | US20040137480 comprises a fusion protein comprising a beta-galactosidase enzyme donor oligopeptide fused to a surrogate protein; gene expression inhibition; for diagnosis/therapy; kits |
| 07/15/2004 | US20040137473 Use of representations of DNA for genetic analysis |
| 07/15/2004 | US20040137472 identifying a compound capable of modulating a splicing event in a pre-mRNA molecule using a cDNA incapable of gene expression in the absence of modulation of a splicing event; using compound(s) identified to treat genetic disorders |
| 07/15/2004 | US20040137471 selecting single-stranded oligomeric compounds for inhibiting RNA expression; RNA interference; modifications include 2'-O alkyl, 2'-O-alkoxyalkyl, 2'-alkoxy, 2'-dimethylaminooxyethoxy, 2'-dimethylaminoethoxyethoxy for example |
| 07/15/2004 | US20040137468 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 07/15/2004 | US20040137459 T. whippelii bacteria rpoB gene which codes for RNA polymerase and is a genetic marker for T. whippelii; probe for detecting its presence in a sample; genetic primers |
| 07/15/2004 | US20040137455 Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene |
| 07/15/2004 | US20040137454 Plasmid for determining cellular polyamine levels comprising DNA construct containing luciferase gene and SV40 promoter; transfection into cultured mammalian cells stimulates translational frameshifting |
| 07/15/2004 | US20040137452 Diagnostic test |
| 07/15/2004 | US20040137451 Method of detecting nucleotide polymorphism |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137447 Human sphingosine-1-phosphate phosphatase |
| 07/15/2004 | US20040137446 Fab I and inhibition of apicomplexan parasites |
| 07/15/2004 | US20040137444 Method for detecting abnormal gene |
| 07/15/2004 | US20040137443 Novel clock gene promoter |
| 07/15/2004 | US20040137441 Modulation of thyroid hormone receptor interactor 3 expression |